$0.21
+0.02 (+10.78%)
Open$0.19
Previous Close$0.19
Day High$0.22
Day Low$0.19
52W High$10.55
52W Low$5.67
Volume—
Avg Volume792.1K
Market Cap13.49M
P/E Ratio30.36
EPS$0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,363.4% upside
Current
$0.21
$0.21
Target
$9.40
$9.40
$5.45
$9.40 avg
$11.97
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.16M | 1.98M | 2.25M |
| Net Income | -609,365 | -497,914 | -589,745 |
| Profit Margin | -28.2% | -25.1% | -26.2% |
| EBITDA | -937,252 | -843,277 | -1,004,481 |
| Free Cash Flow | -606,690 | -515,846 | -697,858 |
| Rev Growth | +2.0% | +14.6% | +17.3% |
| Debt/Equity | 0.62 | 0.60 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |